Yıl: 2022 Cilt: 56 Sayı: 1 Sayfa Aralığı: 35 - 41 Metin Dili: İngilizce DOI: 10.26650/eor.2022895748 İndeks Tarihi: 29-08-2022

Which is the most effective biomaterial in indirect pulp capping? 4- year comparative randomized clinical trial

Öz:
Purpose The aim of this study is to compare the clinical outcomes of Mineral Trioxide Aggregate (MTA) and calcium hydroxide pulp capping after complete caries removal. Materials and Methods In 73 regular patients (47 women, 26 men; age 20.65±3.02 years), having at least one deep carious lesion was recruited. Following complete caries removal, the pulp was indirectly capped with either MTA(n=51) or calcium hydroxide (n =49), randomly. Final restoration with a resin-based composite in a single session was performed. Clinical parameters including pulp vitality, sensitivity to cold or heat stimulants, percussion tests and discomfort during chewing and color were recorded after 6 months, 1 year, 2- year, 3- year and 4- year. Data were analysed statistically (p < 0.05). Results After 4- year, the survival rates were 86% (for MTA), and 82.9% (for calcium hydroxide). Totally, 8 teeth from calcium hydroxide group and 7 teeth from MTA group were endodontically treated. No significant difference was detected between the groups in terms of pulp vitality (p=0.613). Grey discoloration rate was 63% in MTA group. Conclusion Both pulp-capping materials, MTA and calcium hydroxide showed similar clinically successful performance in terms of pulp vitality in the treatment of deep dentin caries lesions after 4- year.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Schwendicke F. Contemporary concepts in carious tissue removal: A review. J Esthet Restor Dent 2017;29:403-8. [CrossRef ]
  • 2. Seux D, Couble ML, Hartmann DJ, Gauthier JP, Magloire H. Odontoblast-like cytodifferentiation of human dental pulp cells in vitro in the presence of a calcium hydroxide-containing cement. Arch Oral Biol 1991;36:117-28. [CrossRef ]
  • 3. Tziafas D, Pantelidou O, Alvanou A, Belibasakis G, Papadimitriou S. The dentinogenic effect of mineral trioxide aggregate (MTA) in short-term capping experiments. Int Endod J 2002;35:245- 54. [CrossRef ]
  • 4. D’Arcangelo C, Di Nardo-Di Maio F, Patrono C, Caputi S. NOS evaluations in human dental pulp-capping with MTA and calcium-hydroxide. Int J Immunopathol Pharmacol 2007;20:27- 32. [CrossRef ]
  • 5. Asgary S, Eghbal MJ, Parirokh M, Ghanavati F, Rahimi H. A comparative study of histologic response to different pulp capping materials and a novel endodontic cement. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;106:609-14. [CrossRef ]
  • 6. Nair PN, Duncan HF, Pitt Ford TR, Luder HU. Histological, ultrastructural and quantitative investigations on the response of healthy human pulps to experimental capping with Mineral Trioxide Aggregate: a randomized controlled trial. 2008. Int Endod J 2009;42:422-44. [CrossRef ]
  • 7. Aeinehchi M, Eslami B, Ghanbariha M, Saffar AS. Mineral trioxide aggregate (MTA) and calcium hydroxide as pulp-capping agents in human teeth: a preliminary report. Int Endod J 2003;36:225- 31. [CrossRef ]
  • 8. Barthel CR, Rosenkranz B, Leuenberg A, Roulet JF. Pulp capping of carious exposures: treatment outcome after 5 and 10 years: a retrospective study. J Endod 2000;26:525-8. [CrossRef ]
  • 9. Cvek M. A clinical report on partial pulpotomy and capping with calcium hydroxide in permanent incisors with complicated crown fracture. J Endod 1978;4:232-7. [CrossRef ]
  • 10. Mente J, Geletneky B, Ohle M, et al. Mineral trioxide aggregate or calcium hydroxide direct pulp capping: an analysis of the clinical treatment outcome. J Endod 2010;36:806-13. [CrossRef ]
  • 11. Okiji T, Yoshiba K. Reparative dentinogenesis induced by mineral trioxide aggregate: a review from the biological and physicochemical points of view. Int J Dent 2009(1687- 8728):464280. [CrossRef ]
  • 12. Ford TR, Torabinejad M, Abedi HR, Bakland LK, Kariyawasam SP. Using mineral trioxide aggregate as a pulp-capping material. J Am Dent Assoc 1996;127:1491-4. [CrossRef ]
  • 13. Min KS, Kim HI, Park HJ, Pi SH, Hong CU, Kim EC. Human pulp cells response to Portland cement in vitro. J Endod 2007;33:163- 6. [CrossRef ]
  • 14. Ricketts D. Management of the deep carious lesion and the vital pulp dentine complex. Br Dent J 2001;191:606-10. [CrossRef ]
  • 15. Schwendicke F, Frencken JE, Bjorndal L, et al. Managing Carious Lesions: Consensus Recommendations on Carious Tissue Removal. Adv Dent Res 2016;28:58-67. [CrossRef ]
  • 16. Innes NP, Frencken JE, Bjorndal L, et al. Managing Carious Lesions: Consensus Recommendations on Terminology. Adv Dent Res 2016;28:49-57. [CrossRef ]
  • 17. Bjorndal L, Reit C, Bruun G, et al. Treatment of deep caries lesions in adults: randomized clinical trials comparing stepwise vs. direct complete excavation, and direct pulp capping vs. partial pulpotomy. Eur J Oral Sci 2010;118:290-7. [CrossRef ]
  • 18. Crespo-Gallardo I, Martin-Gonzalez J, Jimenez-Sanchez MC, Cabanillas-Balsera D, Sanchez-Dominguez B, Segura-Egea JJ. Dentist s knowledge, attitudes and determining factors of the conservative approach in teeth with reversible pulpitis and deep caries lesions. J Clin Exp Dent 2018;10:1205-15. [CrossRef ]
  • 19. Koopaeei MM, Inglehart MR, McDonald N, Fontana M. General dentists’, pediatric dentists’, and endodontists’ diagnostic assessment and treatment strategies for deep carious lesions: A comparative analysis. J Am Dent Assoc 2017;148:64-74. [CrossRef]
  • 20. Schwendicke F, Meyer-Lueckel H, Dorfer C, Paris S. Attitudes and behaviour regarding deep dentin caries removal: a survey among German dentists. Caries Res 2013;47:566-73. [CrossRef ]
  • 21. Stangvaltaite L, Kundzina R, Eriksen HM, Kerosuo E. Treatment preferences of deep carious lesions in mature teeth: Questionnaire study among dentists in Northern Norway. Acta Odontol Scand 2013;71:1532-7. [CrossRef ]
  • 22. Alnahwi TH, Alhamad M, Majeed A, Nazir MA. Management preferences of deep caries in permanent teeth among dentists in Saudi Arabia. Eur J Dent 2018;12:300-4. [CrossRef ]
  • 23. Smail-Faugeron V, Porot A, Muller-Bolla M, Courson F. Indirect pulp capping versus pulpotomy for treating deep carious lesions approaching the pulp in primary teeth: a systematic review. Eur J Paediatr Dent 2016;17:107-12.
  • 24. Weber CM, Alves LS, Maltz M. Treatment decisions for deep carious lesions in the Public Health Service in Southern Brazil. J Public Health Dent 2011;71:265-70. [CrossRef ]
  • 25. Oen KT, Thompson VP, Vena D, et al. Attitudes and expectations of treating deep caries: a PEARL Network survey. Gen Dent 2007;55:197-203.
  • 26. Maltz M, Alves LS, Jardim JJ, Moura Mdos S, de Oliveira EF. Incomplete caries removal in deep lesions: a 10-year prospective study. Am J Dent 2011;24:211-4.
  • 27. Koc Vural U, Kiremitci A, Gokalp S. Randomized Clinical Trial to Evaluate MTA Indirect Pulp Capping in Deep Caries Lesions After 24-Months. Oper Dent 2017;42:470-7. [CrossRef ]
  • 28. Witherspoon DE. Vital pulp therapy with new materials: new directions and treatment perspectives--permanent teeth. Pediatr Dent 2008;30:220-4. [CrossRef ]
  • 29. Schuurs AH, Gruythuysen RJ, Wesselink PR. Pulp capping with adhesive resin-based composite vs. calcium hydroxide: a review. Endod Dent Traumatol 2000;16:240-50. [CrossRef ]
  • 30. Accorinte Mde L, Holland R, Reis A, et al. Evaluation of mineral trioxide aggregate and calcium hydroxide cement as pulpcapping agents in human teeth. J Endod. 2008;34:1-6. [CrossRef ]
  • 31. Chisini LA, Conde MC, Correa MB, et al. Vital Pulp Therapies in Clinical Practice: Findings from a Survey with Dentist in Southern Brazil. Braz Dent J 2015;26:566-71. [CrossRef ]
  • 32. Witherspoon DE, Small JC, Harris GZ. Mineral trioxide aggregate pulpotomies: a case series outcomes assessment. J Am Dent Assoc 2006;137:610-18. [CrossRef ]
  • 33. Sawicki L, Pameijer CH, Emerich K, Adamowicz-Klepalska B. Histological evaluation of mineral trioxide aggregate and calcium hydroxide in direct pulp capping of human immature permanent teeth. Am J Dent 2008;21:262-6.
  • 34. Akhlaghi N, Khademi A. Outcomes of vital pulp therapy in permanent teeth with different medicaments based on review of the literature. Dent Res J (Isfahan) 2015;12:406-17. [CrossRef ]
  • 35. Smail-Faugeron V, Glenny AM, Courson F, Durieux P, Muller-Bolla M, Fron Chabouis H. Pulp treatment for extensive decay in primary teeth. Cochrane Database Syst Rev 2018;5:CD003220. [CrossRef]
  • 36. Tran XV, Salehi H, Truong MT, et al. Reparative Mineralized Tissue Characterization after Direct Pulp Capping with Calcium-Silicate- Based Cements. Materials (Basel) 2019;12: 2102. [CrossRef]
  • 37. Bogen G, Kim JS, Bakland LK. Direct pulp capping with mineral trioxide aggregate: an observational study. J Am Dent Assoc 2008;139:305-15. [CrossRef ]
APA VURAL U, KİREMİTÇİ A, GÖKALP S (2022). Which is the most effective biomaterial in indirect pulp capping? 4- year comparative randomized clinical trial. , 35 - 41. 10.26650/eor.2022895748
Chicago VURAL Uzay KOÇ,KİREMİTÇİ Arlin,GÖKALP Saadet Which is the most effective biomaterial in indirect pulp capping? 4- year comparative randomized clinical trial. (2022): 35 - 41. 10.26650/eor.2022895748
MLA VURAL Uzay KOÇ,KİREMİTÇİ Arlin,GÖKALP Saadet Which is the most effective biomaterial in indirect pulp capping? 4- year comparative randomized clinical trial. , 2022, ss.35 - 41. 10.26650/eor.2022895748
AMA VURAL U,KİREMİTÇİ A,GÖKALP S Which is the most effective biomaterial in indirect pulp capping? 4- year comparative randomized clinical trial. . 2022; 35 - 41. 10.26650/eor.2022895748
Vancouver VURAL U,KİREMİTÇİ A,GÖKALP S Which is the most effective biomaterial in indirect pulp capping? 4- year comparative randomized clinical trial. . 2022; 35 - 41. 10.26650/eor.2022895748
IEEE VURAL U,KİREMİTÇİ A,GÖKALP S "Which is the most effective biomaterial in indirect pulp capping? 4- year comparative randomized clinical trial." , ss.35 - 41, 2022. 10.26650/eor.2022895748
ISNAD VURAL, Uzay KOÇ vd. "Which is the most effective biomaterial in indirect pulp capping? 4- year comparative randomized clinical trial". (2022), 35-41. https://doi.org/10.26650/eor.2022895748
APA VURAL U, KİREMİTÇİ A, GÖKALP S (2022). Which is the most effective biomaterial in indirect pulp capping? 4- year comparative randomized clinical trial. European oral research (Online), 56(1), 35 - 41. 10.26650/eor.2022895748
Chicago VURAL Uzay KOÇ,KİREMİTÇİ Arlin,GÖKALP Saadet Which is the most effective biomaterial in indirect pulp capping? 4- year comparative randomized clinical trial. European oral research (Online) 56, no.1 (2022): 35 - 41. 10.26650/eor.2022895748
MLA VURAL Uzay KOÇ,KİREMİTÇİ Arlin,GÖKALP Saadet Which is the most effective biomaterial in indirect pulp capping? 4- year comparative randomized clinical trial. European oral research (Online), vol.56, no.1, 2022, ss.35 - 41. 10.26650/eor.2022895748
AMA VURAL U,KİREMİTÇİ A,GÖKALP S Which is the most effective biomaterial in indirect pulp capping? 4- year comparative randomized clinical trial. European oral research (Online). 2022; 56(1): 35 - 41. 10.26650/eor.2022895748
Vancouver VURAL U,KİREMİTÇİ A,GÖKALP S Which is the most effective biomaterial in indirect pulp capping? 4- year comparative randomized clinical trial. European oral research (Online). 2022; 56(1): 35 - 41. 10.26650/eor.2022895748
IEEE VURAL U,KİREMİTÇİ A,GÖKALP S "Which is the most effective biomaterial in indirect pulp capping? 4- year comparative randomized clinical trial." European oral research (Online), 56, ss.35 - 41, 2022. 10.26650/eor.2022895748
ISNAD VURAL, Uzay KOÇ vd. "Which is the most effective biomaterial in indirect pulp capping? 4- year comparative randomized clinical trial". European oral research (Online) 56/1 (2022), 35-41. https://doi.org/10.26650/eor.2022895748